These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 15787205

  • 1. [Change of dopamine transporter activity (DAT) during the action of bupropion (in depression)].
    Szabó Z, Argyelán M, Kanyó B, Pávics L, Janka Z.
    Neuropsychopharmacol Hung; 2004 Jun; 6(2):79-81. PubMed ID: 15787205
    [Abstract] [Full Text] [Related]

  • 2. Bupropion occupancy of the dopamine transporter is low during clinical treatment.
    Meyer JH, Goulding VS, Wilson AA, Hussey D, Christensen BK, Houle S.
    Psychopharmacology (Berl); 2002 Aug; 163(1):102-5. PubMed ID: 12185406
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Single photon emission computer tomography of dopamine transporters in monkeys and humans with 99mTc-TRODAT-1.
    Hu P, Chen L, Zhang HQ, Li JR, Liang H.
    Chin Med J (Engl); 2004 Jul; 117(7):1056-9. PubMed ID: 15265382
    [Abstract] [Full Text] [Related]

  • 5. Dopamine transporter availability in medication free and in bupropion treated depression: a 99mTc-TRODAT-1 SPECT study.
    Argyelán M, Szabó Z, Kanyó B, Tanács A, Kovács Z, Janka Z, Pávics L.
    J Affect Disord; 2005 Dec; 89(1-3):115-23. PubMed ID: 16213028
    [Abstract] [Full Text] [Related]

  • 6. Dopamine transporter density may be associated with the depressed affect in healthy subjects.
    Newberg A, Amsterdam J, Shults J.
    Nucl Med Commun; 2007 Jan; 28(1):3-6. PubMed ID: 17159542
    [Abstract] [Full Text] [Related]

  • 7. The striatal dopamine transporter in first-episode, drug-naive schizophrenic patients: evaluation by the new SPECT-ligand[99mTc]TRODAT-1.
    Schmitt GJ, Meisenzahl EM, Frodl T, La Fougère C, Hahn K, Möller HJ, Dresel S.
    J Psychopharmacol; 2005 Sep; 19(5):488-93. PubMed ID: 16166186
    [Abstract] [Full Text] [Related]

  • 8. Evaluating dopamine transporter activity with 99mTc-TRODAT-1 SPECT in drug-naive Tourette's adults.
    Yeh CB, Lee CH, Chou YH, Chang CJ, Ma KH, Huang WS.
    Nucl Med Commun; 2006 Oct; 27(10):779-84. PubMed ID: 16969259
    [Abstract] [Full Text] [Related]

  • 9. Dopamine transporter binding in chronic manganese intoxication.
    Huang CC, Weng YH, Lu CS, Chu NS, Yen TC.
    J Neurol; 2003 Nov; 250(11):1335-9. PubMed ID: 14648150
    [Abstract] [Full Text] [Related]

  • 10. Normal dopamine transporter binding in dopa responsive dystonia.
    Huang CC, Yen TC, Weng YH, Lu CS.
    J Neurol; 2002 Aug; 249(8):1016-20. PubMed ID: 12195447
    [Abstract] [Full Text] [Related]

  • 11. Dopamine transporter density of the basal ganglia assessed with [123I]IPT SPECT in drug-naive children with Tourette's disorder.
    Cheon KA, Ryu YH, Namkoong K, Kim CH, Kim JJ, Lee JD.
    Psychiatry Res; 2004 Jan 15; 130(1):85-95. PubMed ID: 14972371
    [Abstract] [Full Text] [Related]

  • 12. Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging.
    Brunswick DJ, Amsterdam JD, Mozley PD, Newberg A.
    Am J Psychiatry; 2003 Oct 15; 160(10):1836-41. PubMed ID: 14514499
    [Abstract] [Full Text] [Related]

  • 13. No changes in striatal dopamine transporter in antidepressant-treated patients with major depression.
    Wu CK, Chin Chen K, See Chen P, Chiu NT, Yeh TL, Lee IH, Yang YK.
    Int Clin Psychopharmacol; 2013 May 15; 28(3):141-4. PubMed ID: 23524636
    [Abstract] [Full Text] [Related]

  • 14. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
    Ukairo OT, Bondi CD, Newman AH, Kulkarni SS, Kozikowski AP, Pan S, Surratt CK.
    J Pharmacol Exp Ther; 2005 Aug 15; 314(2):575-83. PubMed ID: 15879005
    [Abstract] [Full Text] [Related]

  • 15. Gain of function mutants reveal sites important for the interaction of the atypical inhibitors benztropine and bupropion with monoamine transporters.
    Mortensen OV, Amara SG.
    J Neurochem; 2006 Sep 15; 98(5):1531-40. PubMed ID: 16923164
    [Abstract] [Full Text] [Related]

  • 16. Covalent and noncovalent chemical modifications of arginine residues decrease dopamine transporter activity.
    Volz TJ, Kim M, Schenk JO.
    Synapse; 2004 Jun 15; 52(4):272-82. PubMed ID: 15103693
    [Abstract] [Full Text] [Related]

  • 17. Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors.
    Damaj MI, Carroll FI, Eaton JB, Navarro HA, Blough BE, Mirza S, Lukas RJ, Martin BR.
    Mol Pharmacol; 2004 Sep 15; 66(3):675-82. PubMed ID: 15322260
    [Abstract] [Full Text] [Related]

  • 18. Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes.
    Catafau AM, Tolosa E, DaTSCAN Clinically Uncertain Parkinsonian Syndromes Study Group.
    Mov Disord; 2004 Oct 15; 19(10):1175-82. PubMed ID: 15390019
    [Abstract] [Full Text] [Related]

  • 19. Dopamine transporter binding in depressed patients with anhedonia.
    Sarchiapone M, Carli V, Camardese G, Cuomo C, Di Giuda D, Calcagni ML, Focacci C, De Risio S.
    Psychiatry Res; 2006 Oct 30; 147(2-3):243-8. PubMed ID: 16952448
    [Abstract] [Full Text] [Related]

  • 20. Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment.
    Dresel S, Krause J, Krause KH, LaFougere C, Brinkbäumer K, Kung HF, Hahn K, Tatsch K.
    Eur J Nucl Med; 2000 Oct 30; 27(10):1518-24. PubMed ID: 11083541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.